← Leaderboards
Richard M. Niles
Marshall University
$4,331,556
Attributed
$4,331,556
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2005–18$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$13,852,406 · 10
By mechanism
P20$11,171,612 · 5
R01$1,190,325 · 1
R44$1,068,569 · 1
R03$277,900 · 2
R43$144,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaCell LineTranscription FactorRetinoid Binding ProteinsCell DifferentiationNeoplastic TransformationEnzyme ActivityEnzyme Induction /RepressionInsulinlike Growth FactorPhosphorylationProtein Kinase CRetinoidsResearch PersonnelSourcePaymentGenesFundingGrantEnsureGrowthAnticancer ResearchAcetylationCommercializationAnimal Model
Grant awards (25)
Bioengineering a non-pathogenic bacteria to produce medically-relevant biopolymers$650,088
R44 · FY2018 · GM · contact PI
Bioengineering a non-pathogenic bacteria to produce medically-relevant biopolymers$418,481
R44 · FY2017 · GM · contact PI
Bioengineering a non-pathogenic bacteria to produce medically-relevant biopolymers$144,000
R43 · FY2015 · GM · contact PI
Transcription Factors in Cancer$490,224
P20 · FY2009 · RR · contact PI
Transcription Factors in Cancer$1,777,401
P20 · FY2008 · RR · contact PI
MARSHALL U COBRE: ADMINISTRATIVE COREOIR=$475,508
P20 · FY2008 · RR · contact PI
Transcription Factors in Cancer$1,780,986
P20 · FY2007 · RR · contact PI
MARSHALL U COBRE: ADMINISTRATIVE COREOIR=$429,163
P20 · FY2007 · RR · contact PI
RARbeta in Melanoma: Epigenetic Regulation by Nutrients$67,900
R03 · FY2007 · CA · contact PI
Transcription Factors in Cancer$1,775,439
P20 · FY2006 · RR · contact PI
MARSHALL U COBRE: ADMINISTRATIVE COREOIR=$441,410
P20 · FY2006 · RR · contact PI
RARbeta in Melanoma: Epigenetic Regulation by Nutrients$70,000
R03 · FY2006 · CA · contact PI
Transcription Factors in Cancer$1,868,865
P20 · FY2005 · RR
MARSHALL U COBRE: ADMINISTRATIVE COREOIR=$304,681
P20 · FY2005 · RR
Transcription Factors in Cancer$1,827,935
P20 · FY2004 · RR
RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION$217,440
R01 · FY2004 · CA
Resveratrol and Human Melanoma$70,000
R03 · FY2004 · CA
RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION$36,880
R01 · FY2004 · CA
RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION$217,440
R01 · FY2003 · CA
Resveratrol and Human Melanoma$70,000
R03 · FY2003 · CA
RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION$35,969
R01 · FY2003 · CA
RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION$217,440
R01 · FY2002 · CA
RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION$30,650
R01 · FY2002 · CA
RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION$217,440
R01 · FY2001 · CA
RETINOIDS &PROTEIN KINASE C IN MELANOMA DIFFERENTIATION$217,066
R01 · FY2000 · CA